Synthesis, characterization, and lipoxygenase inhibition of salicylaldehyde-derived schiff base metal complexes: enzymatic and in silico evaluation using quinoa lipoxygenase

ArticleAçık Erişim

Özet

In the present study, novel Schiff base ligands were synthesized via the condensation of salicylaldehyde derivatives with o-aminophenol, and their metal complexes with Co(II), Ni(II), Cu(II), Zn(II), Cd(II), and UO₂(VI) metal actetates were successfully prepared. The compounds were comprehensively characterized using FT-IR, 1H-NMR, 13C-NMR, UV–Vis spectroscopy, X-ray diffraction (XRD), scanning electron microscopy (SEM), and magnetic susceptibility measurements. FT-IR spectra confirmed azomethine (C = N) coordination through characteristic bands at 1612–1630 cm−1, while 1H-NMR spectra exhibited diagnostic azomethine proton signals at δ 8.84–8.62 ppm. XRD analysis revealed a semi-crystalline nature with prominent reflections at 2θ = 18.02° and 20.87°, and SEM images demonstrated nanorod-like morphologies. Magnetic moment values supported the proposed coordination geometries of the paramagnetic complexes. The biological activity of the synthesized compounds was investigated through in vitro inhibition studies against lipoxygenase (LOX), a ~ 97 kDa enzyme purified from Chenopodium quinoa Willd. with 77.89% purity and 7.24% yield. All compounds exhibited competitive inhibition toward LOX, with inhibition constants (Ki) in the range of 0.014 ± 0.002 to 0.858 ± 0.194 μM, indicating remarkable inhibitory potency. Molecular docking studies further substantiated the experimental results by revealing key hydrogen-bonding and π-cation interactions between the most active compounds and essential amino acid residues within the LOX active site. Overall, the results demonstrate that these Schiff base metal complexes represent promising candidates for the development of potent LOX inhibitors. © The Author(s) 2026.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/10315Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1007/s00210-025-04955-6Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorEreminsoy, Ergün
dc.contributor.authorDemir, Yeliz
dc.contributor.authorYıldırım, Sümeyra Tuna
dc.contributor.authorTürkeş, Cüneyt
dc.contributor.authorKüfrevioğlu, Ömer İrfan
dc.date.accessioned2026-10-18T20:25:33.201947981Z
dc.date.available2026-10-18T20:25:33.201947981Z
dc.date.issued2026
dc.description.abstractIn the present study, novel Schiff base ligands were synthesized via the condensation of salicylaldehyde derivatives with o-aminophenol, and their metal complexes with Co(II), Ni(II), Cu(II), Zn(II), Cd(II), and UO₂(VI) metal actetates were successfully prepared. The compounds were comprehensively characterized using FT-IR, 1H-NMR, 13C-NMR, UV–Vis spectroscopy, X-ray diffraction (XRD), scanning electron microscopy (SEM), and magnetic susceptibility measurements. FT-IR spectra confirmed azomethine (C = N) coordination through characteristic bands at 1612–1630 cm−1, while 1H-NMR spectra exhibited diagnostic azomethine proton signals at δ 8.84–8.62 ppm. XRD analysis revealed a semi-crystalline nature with prominent reflections at 2θ = 18.02° and 20.87°, and SEM images demonstrated nanorod-like morphologies. Magnetic moment values supported the proposed coordination geometries of the paramagnetic complexes. The biological activity of the synthesized compounds was investigated through in vitro inhibition studies against lipoxygenase (LOX), a ~ 97 kDa enzyme purified from Chenopodium quinoa Willd. with 77.89% purity and 7.24% yield. All compounds exhibited competitive inhibition toward LOX, with inhibition constants (Ki) in the range of 0.014 ± 0.002 to 0.858 ± 0.194 μM, indicating remarkable inhibitory potency. Molecular docking studies further substantiated the experimental results by revealing key hydrogen-bonding and π-cation interactions between the most active compounds and essential amino acid residues within the LOX active site. Overall, the results demonstrate that these Schiff base metal complexes represent promising candidates for the development of potent LOX inhibitors. © The Author(s) 2026.
dc.description.sponsorshipOpen access funding provided by the Scientific and Technological Research Council of T\u00FCrkiye (T\u00DCB\u0130TAK).
dc.identifier.doi10.1007/s00210-025-04955-6
dc.identifier.eissn1432-1912
dc.identifier.endpage8990
dc.identifier.issn0028-1298
dc.identifier.issue6
dc.identifier.pmcidPMC13086667
dc.identifier.pmid41540217
dc.identifier.scopus2-s2.0-105027670774
dc.identifier.startpage8975
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/10315
dc.identifier.volume399
dc.identifier.wosWOS:001663166300001
dc.language.isoen
dc.publisherSpringer Science and Business Media Deutschland GmbH
dc.relation.ispartofNaunyn-Schmiedeberg's Archives of Pharmacology
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCharacterization
dc.subjectLipoxygenase
dc.subjectMetal complexes
dc.subjectMolecular docking
dc.subjectSchiff base
dc.subjectAldehydes
dc.subjectCoordination Complexes
dc.subjectLipoxygenase Inhibitors
dc.subjectMolecular Docking Simulation
dc.subjectSchiff Bases
dc.subject2 [[(2 hydroxyphenyl)imino]methyl] 4 nitrophenol
dc.subject4 [[(2 hydroxyphenyl)imino]methyl] benzene 1,3 diol
dc.subjectessential amino acid
dc.subjectmetal complex
dc.subjectsalicylaldehyde
dc.subjectunclassified drug
dc.subjectaldehyde
dc.subjectcoordination compound
dc.subjectlipoxygenase inhibitor
dc.subjectArticle
dc.subjectbinding affinity
dc.subjectbiological activity
dc.subjectcarbon nuclear magnetic resonance
dc.subjectChenopodium quinoa
dc.subjectcompetitive inhibition
dc.subjectcomplex formation
dc.subjectcomputer model
dc.subjectcontrolled study
dc.subjectdeprotonation
dc.subjectelectrospray mass spectrometry
dc.titleSynthesis, characterization, and lipoxygenase inhibition of salicylaldehyde-derived schiff base metal complexes: enzymatic and in silico evaluation using quinoa lipoxygenase
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus5
rdl.citation.wos6
rdl.departmentDepartment of Analytical Chemistry, Faculty of Pharmacy, Erzincan Binali Yıldırım University, Erzincan, 24002, Türkiye. | Department of Biochemistry, Faculty of Pharmacy, Erzincan Binali Yıldırım University, Erzincan, 24002, Türkiye.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)